(HealthDay)—Lung transplantation is successful for patients with COVID-19-associated acute respiratory distress syndrome (ARDS), with high survival, according to a study published online Jan. 27 in ...
An initial trial suggests that a new drug, originally developed for use with cancer patients, could improve the survival of patients with acute respiratory distress syndrome (ARDS). The patients in ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Survival rates following transplantation did not differ ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. In a single-center case series published in JAMA, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results